6533b820fe1ef96bd127a647
RESEARCH PRODUCT
Pulmonary hypertension associated with ponatinib therapy
David MontaniM. GeorgesAurélie GrandvuilleminFleur-marie QuilotNicolas FavroltPhilippe CamusPhilippe CamusPhilippe BonniaudGuillaume BeltramoClément Foignotsubject
Pulmonary and Respiratory Medicinemedicine.medical_specialtyCardiac outputeducationMEDLINEDasatinib030204 cardiovascular system & hematology[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract03 medical and health scienceschemistry.chemical_compoundMyelogenous0302 clinical medicineResearch letterInternal medicinehemic and lymphatic diseasesMedicineChronic myelogenous leukaemiaIntensive care medicineTyrosine kinasehealth care economics and organizationsbusiness.industryInhibitorsPonatinibDisease progressionArterial-hypertensionmedicine.diseasePulmonary hypertension3. Good healthLeukemia030228 respiratory systemchemistrybusiness[ SDV.MHEP.PSR ] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractdescription
IF 8.332; International audience; A case of pulmonary hypertension associated with ponatinib therapy in a chronic myelogenous leukaemia patient.
year | journal | country | edition | language |
---|---|---|---|---|
2016-02-01 |